id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0147-0025,FDA,FDA-2011-D-0147,"Guidance for Industry; Demonstrating the Substantial Equivalence of a
New Tobacco Product: Responses to Frequently Asked Questions (Edition 3)",Other,Guidance,2016-12-14T05:00:00Z,2016,12,2016-12-14T05:00:00Z,,2024-11-07T23:50:17Z,,1,0,0900006482406b59
FDA-2011-D-0147-0024,FDA,FDA-2011-D-0147,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Guidance for Industry and Food and
Drug Administration Staff; Section 905(j) Reports: Demonstrating
Substantial Equivalence for Tobacco Products and Demonstrating the
Substantial Equivalence of a New Tobacco Product: Responses to
Frequently Asked Questions",Notice,Notice of Approval,2016-02-29T05:00:00Z,2016,2,2016-02-29T05:00:00Z,,2016-03-02T17:05:45Z,2016-04222,0,0,0900006481e8f4c8